Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
BMC Health Services Research|January 6, 2025
Commissioning health services for First Nations, regional, and remote populations: a scoping reviewHenry Boer, Janya McCalman, Chris Doran, et al.Breast Cancer Research and Treatment|February 16, 2015
Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancerMichelle W Wong-Brown, Cliff J Meldrum, Jane E Carpenter, et al.Biopreservation and Biobanking|February 3, 2017
Business Planning for a Campus-Wide BiobankTamsin E Tarling, Frances Lasser, Candace Carter, et al.Asia-Pacific Journal of Clinical Oncology|June 24, 2021
Barriers and potential solutions to international collaboration in neuro-oncology clinical trials: Challenges from the Australian perspectiveBenjamin Y Kong, Candace Carter, Anna K Nowak, et al.The Lancet. Oncology|June 6, 2007
Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trialMartin R Stockler, Rachel O'Connell, Anna K Nowak, et al.Biopreservation and Biobanking|March 14, 2014
A framework for biobank sustainabilityPeter H Watson, Sara Y Nussbeck, Candace Carter, et al.BMJ Open|September 14, 2022
Multi-Arm GlioblastoMa Australasia (MAGMA): protocol for a multiarm randomised clinical trial for people affected by glioblastomaBenjamin Y Kong, Hao-Wen Sim, Elizabeth H Barnes, et al.Nature Genetics|March 3, 2015
The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemiasAnna K Andersson, Jing Ma, Jianmin Wang, et al.Cancer Research|August 17, 2011
Common breast cancer susceptibility loci are associated with triple-negative breast cancerKristen N Stevens, Celine M Vachon, Adam M Lee, et al.Nature Genetics|November 1, 2011
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancerChristopher A Haiman, Gary K Chen, Celine M Vachon, et al.Pageof 5